查尔酮是一种黄酮类化合物,在植物中广泛生物合成。研究表明,从水果和蔬菜中食用黄酮类化合物或使用单独的成分可以降低患皮肤病的风险。然而,查尔酮对黑色素生成和炎症的影响尚未得到充分研究。这项研究的目的是评估2'-羟基-3,4'-二甲氧基查尔酮(3,4'-DMC)的抗黑色素生成和抗炎作用,2'-羟基-4,4'-二甲氧基查尔酮(4,4'-DMC),2\'-羟基-3\',4\'-二甲氧基查尔酮(3\',4\'-DMC),和2\'-羟基-4\',6\'-二甲氧基查尔酮(4\',6'-DMC)。在2'-羟基-4'-甲氧基查耳酮的衍生物中,4\',6'-DMC表现出最有效的黑素生成抑制和抗炎作用。正如各种生物测定所证明的那样,4\',6'-DMC无细胞毒性,显著降低酪氨酸酶的表达,酪氨酸酶相关蛋白(TRP)-1和TRP-2酶。此外,它通过下调小眼症相关转录因子(MITF)降低B16F10黑色素瘤细胞中的细胞黑色素含量和细胞内酪氨酸酶活性,cAMP依赖性蛋白激酶(PKA),cAMP反应元件结合蛋白(CREB),p38,c-Jun氨基末端激酶(JNK),β-连环蛋白,糖原合成酶激酶-3β(GSK3β),和蛋白激酶B(AKT)蛋白,同时上调细胞外信号调节激酶(ERK)和β-catenin。此外,用4\'治疗,6'-DMC显着减轻脂多糖(LPS)诱导的NO表达,PGE2,炎性细胞因子,COX-2和iNOS蛋白。总的来说,4\',6'-DMC处理通过减少核因子κB(NF-κB)显着减轻LPS诱导的损伤,p38,JNK蛋白水平,和NF-kB/p65核易位。最后,4的局部适用性,在初步的人体皮肤刺激试验中评估了6'-DMC,没有发现不良反应。这些发现表明,4',6'-DMC可以提供用作药妆品和软膏中的功能性成分的新可能性。
Chalcone is a type of flavonoid compound that is widely biosynthesized in plants. Studies have shown that consuming flavonoids from fruits and vegetables or applying individual ingredients reduces the risk of skin disease. However, the effects of chalcone on melanogenesis and inflammation have not been fully investigated. The aim of this study was to evaluate the anti-melanogenic and anti-inflammatory effects of 2\'-hydroxy-3,4\'-dimethoxychalcone (3,4\'-DMC), 2\'-hydroxy-4,4\'-dimethoxychalcone (4,4\'-DMC), 2\'-hydroxy-3\',4\'-dimethoxychalcone (3\',4\'-DMC), and 2\'-hydroxy-4\',6\'-dimethoxychalcone (4\',6\'-DMC). Among the derivatives of 2\'-hydroxy-4\'-methoxychalcone, 4\',6\'-DMC demonstrated the most potent melanogenesis-inhibitory and anti-inflammatory effects. As evidenced by various biological assays, 4\',6\'-DMC showed no cytotoxicity and notably decreased the expression of tyrosinase, tyrosinase-related protein (TRP)-1, and TRP-2 enzymes. Furthermore, it reduced cellular melanin content and intracellular tyrosinase activity in B16F10 melanoma cells by downregulating microphthalmia-associated transcription factor (MITF), cAMP-dependent protein kinase (PKA), cAMP response element-binding protein (CREB), p38, c-Jun N-terminal kinase (JNK), β-catenin, glycogen synthase kinase-3β (GSK3β), and protein kinase B (AKT) proteins, while upregulating extracellular signal-regulated kinase (ERK) and p-β-catenin. Additionally, treatment with 4\',6\'-DMC significantly mitigated the lipopolysaccharide (LPS)-induced expression of NO, PGE2, inflammatory cytokines, COX-2, and iNOS proteins. Overall, 4\',6\'-DMC treatment notably alleviated LPS-induced damage by reducing nuclear factor kappa B (NF-κB), p38, JNK protein levels, and NF-kB/p65 nuclear translocation. Finally, the topical applicability of 4\',6\'-DMC was evaluated in a preliminary human skin irritation test and no adverse effects were found. These findings suggest that 4\',6\'-DMC may offer new possibilities for use as functional ingredients in cosmeceuticals and ointments.